Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Net Income Loss of $705.10 million for the year ending 2025.
- ZIMMER BIOMET HOLDINGS, INC. showed a decrease of -22.0% in Net Income Loss from 2024 to 2025.
- This data is from ZIMMER BIOMET HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $173.10 million | Q4 2014: $153.80 million | Q1 2015: $171.40 million | Q2 2015: -$173.60 million | Q3 2015: $22.20 million | Q4 2015: $127.00 million | Q1 2016: $108.80 million | Q2 2016: -$31.30 million | Q3 2016: $158.80 million | Q4 2016: $69.60 million | Q1 2017: $299.40 million | Q2 2017: $184.20 million | Q3 2017: $98.80 million | Q4 2017: $1.23 billion | Q1 2018: $174.70 million | Q2 2018: $185.00 million | Q3 2018: $162.20 million | Q4 2018: -$901.10 million | Q1 2019: $246.10 million | Q2 2019: $133.70 million | Q3 2019: $431.10 million | Q4 2019: $320.70 million | Q1 2020: -$508.50 million | Q2 2020: -$206.60 million | Q3 2020: $242.50 million | Q4 2020: $333.70 million | Q1 2021: $198.10 million | Q2 2021: $141.90 million | Q3 2021: $145.60 million | Q1 2022: $14.20 million | Q2 2022: $153.70 million | Q3 2022: $194.00 million | Q1 2023: $232.50 million | Q2 2023: $209.60 million | Q3 2023: $162.70 million | Q1 2024: $172.40 million | Q2 2024: $242.80 million | Q3 2024: $249.10 million | Q1 2025: $182.00 million | Q2 2025: $152.80 million | Q3 2025: $230.90 million.
- Over the full 18 years of available data (2008 to 2025), ZIMMER BIOMET HOLDINGS, INC.'s Net Income Loss has declined by 16.9%.
- Historical annual values: Fiscal year 2025: $705.10 million | Fiscal year 2024: $903.80 million | Fiscal year 2023: $1.02 billion | Fiscal year 2022: $231.40 million | Fiscal year 2021: $401.60 million | Fiscal year 2020: -$138.90 million | Fiscal year 2019: $1.13 billion | Fiscal year 2018: -$379.20 million | Fiscal year 2017: $1.81 billion | Fiscal year 2016: $305.90 million | Fiscal year 2015: $147.00 million | Fiscal year 2014: $720.30 million | Fiscal year 2013: $780.40 million | Fiscal year 2012: $755.00 million | Fiscal year 2011: $760.80 million | Fiscal year 2010: $596.90 million | Fiscal year 2009: $717.40 million | Fiscal year 2008: $848.60 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: